TBK1 and amyotrophic lateral sclerosis: In the ALS/FTD context, truncating changes, including nonsense, frameshift, and splice-site variants, are most readily interpreted as pathogenic due to the reduced dosage of TBK1 resulting from protein truncation or nonsense-mediated decay.